References
- Topamax. Prescribing information [Internet] Available from: https://www.topamax.com/sites/default/files/topamax.pdfAccessed July 12, 2016
- ShankRPGardockiJFStreeterAJMaryanoffBEAn overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of actionEpilepsia200041Suppl 1S3S9
- KuznieckyRHoSPanJModulation of cerebral GABA by topiramate, lamotrigine, and gabapentin in healthy adultsNeurology200258336837211839834
- PetroffOARothmanDLBeharKLMattsonRHHuman brain GABA levels rise after initiation of vigabatrin therapy but fail to rise further with increasing doseNeurology1996465145914638628502
- SillsGJButlerEForrestGRatnarajNPatsalosPNBrodieMJVigabatrin, but not gabapentin or topiramate, produces concentration-related effects on enzymes and intermediates of the GABA shunt in rat brain and retinaEpilepsia200344788689212823570
- ErranteLDPetroffOACAcute effects of gabapentin and pregabalin on rat forebrain cellular GABA, glutamate, and glutamine concentrationsSeizure200312530030612810343
- SchieferUVisual field defects – essentials for neurologistsJ Neurol2003250440741112760380
- FraunfelderFWFraunfelderFTKeatesEUTopiramate-associated acute, bilateral, secondary angle-closure glaucomaOphthalmology2004111110911114711721
- MandalAChatterjeeSBoseSGangulyGOcular adverse effects of topiramate: two case reportsIndian J Pharmacol200840627828021279186
- QuagliatoLBBarellaKAbreu NetoJMQuagliatoEMTopiramate-associated acute, bilateral, angle-closure glaucoma: case reportArq Bras Oftalmol2013761484923812529
- KjellströmSBruunAIsakssonBErikssonTAndréassonSPonjavicVRetinal function and histopathology in rabbits treated with topiramateDoc Ophthalmol2006113317918617111186
- KälviäinenRNousiainenIVisual field defects with vigabatrin: epidemiology and therapeutic implicationsCNS Drugs200115321723011463129
- WildJMMartinezCReinshagenGHardingGFCharacteristics of a unique visual field defect attributed to vigabatrinEpilepsia199940121784179410612345
- YonedaSTanakaEGotoWOtaTHaraHTopiramate reduces excitotoxic and ischemic injury in the rat retinaBrain Res20039671–225726612650986
- AltmanDGPractical Statistics for Medical ResearchBoca Raton, FLChapman & Hall/CRC1991611
- NousiainenDIMäntyjärviMKälviäinenRVisual function in patients treated with the GABAergic anticonvulsant drug tiagabineClin Drug Investig2012206393400
- SillsGJPatsalosPNButlerEForrestGRatnarajNBrodieMJVisual field constriction: accumulation of vigabatrin but not tiagabine in the retinaNeurology200157219620011468302
- VerrottiALobefaloLPrioloTColor vision in epileptic adolescents treated with valproate and carbamazepineSeizure200413641141715276145
- ChristensenJAndreasenFPoulsenJHDamMRandomized, concentration-controlled trial of topiramate in refractory focal epilepsyNeurology20036191210121814610122
- ArndtCFSalleMDeramburePHDefoort-DhellemmesSHacheJ-CThe effect on vision of associated treatments in patients taking vigabatrin: carbamazepine versus valproateEpilepsia200243881281712180998
- PaulusWSchwarzGSteinhoffBJThe effect of anti-epileptic drugs on visual perception in patients with epilepsyBrain J Neurol1996119Pt 2539549
- VerrottiAMancoRMatricardiSFranzoniEChiarelliFAntiepileptic drugs and visual functionPediatr Neurol200736635336017560495
- ZaccaraGPeruccaPGangemiPFThe adverse event profile of pregabalin across different disorders: a meta-analysisEur J Clin Pharmacol201268690391222271298
- DubocAHanoteauNSimonuttiMVigabatrin, the GABA-transaminase inhibitor, damages cone photoreceptors in ratsAnn Neurol200455569570515122710
- PandayVARheeDJReview of sulfonamide-induced acute myopia and acute bilateral angle-closure glaucomaCompr Ophthalmol Update20078527127618201514
- ThambiLKapcalaLPChambersWTopiramate-associated secondary angle-closure glaucoma: a case seriesArch Ophthalmol20021208110812149075
- TripathiRCTripathiBJHaggertyCDrug-induced glaucomas: mechanism and managementDrug Saf2003261174976712908846
- IkedaNIkedaTNagataMMimuraOCiliochoroidal effusion syndrome induced by sulfa derivativesArch Ophthalmol200212012177512470170
- NateshSRajashekharaSKRaoASDShettyBTopiramate-induced angle closure with acute myopia, macular striaeOman J Ophthalmol201031262820606870
- TanakaSChumanYAkaikeKDoiWA case of topiramate-induced angle closure glaucomaNihon Shinkei Seishin Yakurigaku Zasshi2011313131133 Japanese21800704
- SpaccapeloLLeschiuttaSAureaCFerrariATopiramate-associated acute glaucoma in a migraine patient receiving concomitant citalopram therapy: a case-reportCases J2009218719171058
- WillettMCEdwardDPRefractory topiramate-induced angle-closure glaucoma in a man: a case reportJ Med Case Reports2011533
- Asensio-SánchezVMTorreblanca-AgüeraBMartínez-CalvoSCalvoMJRodríguezRSevere ocular side effects with TopamaxArch Soc Esp Oftalmol2006816345348 Spanish16804780
- ForoozanRBuonoLMFoggy visual field defectSurv Ophthalmol200348444745112850232
- MacgregorEARosenbergJDKurthTSex-related differences in epidemiological and clinic-based headache studiesHeadache201151684385921631472
- McHughJCDelantyNEpidemiology and classification of epilepsy: gender comparisonsInt Rev Neurobiol200883112618929074
- Al AjlouniSShormanADaoudASThe efficacy and side effects of topiramate on refractory epilepsy in infants and young children: a multi-center clinical trialSeizure200514745946316087357
- ChungSSA review of the efficacy and safety of extended-release topiramate in the adjunctive treatment for refractory partial-onset seizuresTher Adv Neurol Disord20158313113625941540
- ChungSSFakhouryTAHoganREOnce-daily USL255 as adjunctive treatment of partial-onset seizures: randomized phase III studyEpilepsia20145571077108724902983